SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI6/11/2007 8:34:21 PM
  Read Replies (1) of 295
 
Binary event seen by Lazard...

09:40 am Neurogesx: Lazard Capital initiates Buy. Target $13. Lazard initiates NGSX with a Buy and a $13 tgt. Although the firm views the stock as a binary play, they say the co has in NGX4010, its high concentration capsaicin patch, a differentiated asset with limited clinical risk, targeting the vast and unsatisfied neuropathic pain market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext